报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | -14.96% | -15.08% | -18.26% | 144/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
2024-06-30 | -12.65% | 33.46% | -63.23% | 146/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
2024-03-31 | -7.75% | 6.63% | 77.46% | 142/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
2023-12-31 | -34.39% | 12.6% | -164.54% | 142/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
2023-09-30 | -13% | 54.48% | 31.61% | 137/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
2023-06-30 | -19.01% | -7.52% | -129.04% | 148/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
2023-03-31 | -8.3% | -12.01% | 78.91% | 143/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
2022-12-31 | -39.35% | 14.16% | -37.78% | 146/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
2022-09-30 | -28.56% | -16.81% | -61.54% | 139/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
2022-06-30 | -17.68% | -71.82% | -138.6% | 145/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
2022-03-31 | -7.41% | 2% | 83.84% | 134/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
2021-12-31 | -45.84% | 17.21% | -87.48% | 145/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
2021-09-30 | -24.45% | 41.62% | -137.61% | 131/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
2021-06-30 | -10.29% | 2% | 81.42% | 137/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
2020-12-31 | -55.37% | 27.03% | -32.21% | 142/160 | 3.74% | 汇宇制药 | 28.14% | 行业排名> |
2020-09-30 | -41.88% | 2% | 44.81% | 117/160 | 3.22% | 哈三联 | 27.17% | 行业排名> |
2019-12-31 | -75.88% | -39.72% | -39.72% | 134/160 | 2.78% | 汇宇制药 | 55.94% | 行业排名> |
2018-12-31 | -54.31% | 2% | 2% | 133/160 | 7.09% | 河化股份 | 45.32% | 行业排名> |